Eloralintide Reconstitution: 10 mg Vial, Water Volume, Units (2026)

Reviewed by

Brandon Johnson — Certified Personal Trainer, Nutrition Coach & Peptide Research Consultant

Brandon Johnson is a certified personal trainer, nutrition coach, and peptide research consultant with a background in kinesiology and over 15 years of experience in fitness and wellness. He reviews all PSPeptides educational content for scientific accuracy and practical relevance.

Eloralintide reconstitution for the 10 mg research vial begins with one number: 1.0 mL of bacteriostatic water produces a 10 mg/mL solution in which each unit on a U-100 insulin syringe holds 0.1 mg, so the 1, 3, 6 and 9 mg weekly doses from Lilly’s Phase 2 trial read as 10, 30, 60 and 90 units. Adding 2.0 or 2.5 mL instead dilutes the vial to 5 or 4 mg/mL and changes every unit figure.

Eloralintide (LY3841136), Eli Lilly’s amylin receptor agonist, is investigational, with no approval from the FDA or any other regulator as of October 2026 (Lilly, What to know about eloralintide), so the vial described here is a laboratory material handled under a research protocol. This guide covers the eloralintide 10 mg vial from PSPeptides, from diluent volume to syringe reading and storage; the molecule itself is covered in the eloralintide research guide.

The Reconstitution Numbers in One Place

ItemValue for the 10 mg vial
Vial contents10 mg lyophilized eloralintide, single vial; lot COA on the product page
DiluentBacteriostatic water, drawn with a U-100 insulin syringe
Standard volume1.0 mL, giving 10 mg/mL; 1 unit = 0.10 mg
Alternative volumes2.0 mL, giving 5 mg/mL (1 unit = 0.05 mg); 2.5 mL, giving 4 mg/mL (1 unit = 0.04 mg)
Doses modelled on the trial1, 3, 6 and 9 mg once weekly; 3→6→9 mg escalation arm
Units at 10 mg/mL10, 30, 60 and 90 units for 1, 3, 6 and 9 mg
Doses per vialTen 1 mg; three 3 mg (1 mg left); one 6 mg (4 mg left); one 9 mg (1 mg left)
Syringe scaleU-100 insulin syringe: 1 mL = 100 units; 1 unit = 0.01 mL
Storage, lyophilizedFrozen or refrigerated, away from light (standard lyophilized-peptide handling)
Storage, reconstituted2–8 °C, used within about 28 days (convention; no eloralintide-specific stability data)
Regulatory statusInvestigational; not approved by any regulator as of October 2026

Arithmetic from vial mass ÷ diluent volume; trial doses from Billings et al., The Lancet 2025; storage values are the conventional handling for lyophilized research peptides, not eloralintide-specific data.

Eloralintide reconstitution of a 10 mg vial: bacteriostatic water volume, concentration and syringe units

What a 10 mg Vial Needs: Supplies and Their Role

Four items cover an eloralintide reconstitution: the sealed 10 mg vial, bacteriostatic water, U-100 insulin syringes and alcohol pads. The water is the diluent of choice for a vial that will be entered more than once, because its preservative is what permits repeated use over several weeks, whereas plain sterile water suits single-use preparations only; our explainer on what bacteriostatic water is covers that difference.

  • Eloralintide 10 mg vial: a single lyophilized vial whose lot number, taken from the COA, goes onto the reconstitution label.
  • Bacteriostatic water: 1.0, 2.0 or 2.5 mL per vial, depending on the concentration chosen below.
  • U-100 insulin syringes: one for the water transfer and a fresh one for each dose draw; 1 mL equals 100 units.
  • Alcohol pads: both stoppers are swabbed before every puncture, including each later dose draw.
  • Peptide injection pen: an optional alternative for the dose-draw step; reconstitution itself still uses a syringe.
  • Peptide calculator: a free check on the unit figures for any volume and dose.

Choosing the Diluent Volume: 1 mL, 2 mL or 2.5 mL

The volume added sets the concentration, and the concentration sets what each syringe unit is worth; nothing else in eloralintide reconstitution changes the arithmetic. Dividing 10 mg by the millilitres added gives the concentration in mg/mL, and dividing that figure by 100 gives the milligrams held in a single unit, which is the number a label should carry.

Bacteriostatic water addedConcentrationmg per unitSingle-draw doses on a 1 mL syringeTypical use
1.0 mL10 mg/mL0.10 mgAll of 1, 3, 6 and 9 mgProtocols modelled on the 3, 6 and 9 mg Phase 2 arms
2.0 mL5 mg/mL0.05 mg1 and 3 mg; 6 and 9 mg need two draws eachLow-dose work where 1 mg = 20 units is easier to read
2.5 mL4 mg/mL0.04 mg1 and 3 mg; 6 mg needs two draws, 9 mg threeVery low or fractional doses

Arithmetic only: concentration = 10 mg ÷ mL added; mg per unit = concentration ÷ 100. Eloralintide-specific stability data have not been published.

Most laboratory designs default to 1.0 mL, since every dose Lilly studied in Phase 2 (Billings et al., The Lancet 2025) then sits inside one 1 mL syringe and the unit figures are round. The larger volumes earn their place at 1 mg or below, where 10 units leaves little margin for a reading error and 20 or 25 units is easier to measure.

Concentration options for a 10 mg eloralintide vial at 1 mL, 2 mL and 2.5 mL of bacteriostatic water

Eloralintide Reconstitution Step by Step

The procedure below is written for a laboratory bench and follows standard lyophilized-peptide handling. Nothing in it is specific to eloralintide beyond the vial size and the trial doses, because eloralintide-specific stability data have not been published; the molecule is a 37-amino-acid analogue of human amylin carrying a C20 fatty diacid (Briere et al., Molecular Metabolism 2025), and it is handled like any other lyophilized peptide.

  1. Both vials are brought to room temperature. The lyophilized vial comes out of the freezer or refrigerator and stands until it is no longer cold to the touch, so that condensation does not form inside it when the seal is opened.
  2. The flip caps are removed and both rubber stoppers are swabbed with an alcohol pad and allowed to dry.
  3. The chosen volume of bacteriostatic water is drawn into a U-100 insulin syringe: 1.0 mL, the 100-unit mark, for a 10 mg/mL solution.
  4. The needle is inserted through the eloralintide stopper at an angle so that the water runs down the inside of the glass rather than landing on the lyophilized cake, with the plunger pressed slowly.
  5. The needle is withdrawn and the vial is swirled gently or rolled between the palms until the cake has dissolved into a clear solution. It is never shaken, and a solution that stays cloudy or shows particles is set aside rather than used.
  6. The vial is labelled with the reconstitution date, the concentration (for example “10 mg/mL, 1 unit = 0.1 mg”) and the lot number from the COA, then refrigerated at 2–8 °C.
  7. For each research dose, the stopper is swabbed again and a fresh syringe draws the calculated units, such as 30 units for 3 mg at 10 mg/mL.

Two steps do most of the work. Running the water down the glass instead of onto the cake, and swirling instead of shaking, are the conventional precautions for any peptide solution, and they are the reason an eloralintide reconstitution takes a few quiet minutes rather than a few seconds. The general technique is the same one described in our peptide reconstitution guide; only the vial mass and the dose table are specific to this vial.

Reading the Syringe: Units per Research Dose at Each Concentration

A U-100 insulin syringe is graduated in units, with 100 units to the millilitre, so the units for any dose are the volume in millilitres multiplied by 100. The table gives each Phase 2 dose at the three concentrations above; cells marked as two or three draws exceed a 1 mL syringe and are split into whole draws.

Concentration (water added)1 mg3 mg6 mg9 mg
10 mg/mL (1.0 mL)0.10 mL = 10 units0.30 mL = 30 units0.60 mL = 60 units0.90 mL = 90 units
5 mg/mL (2.0 mL)0.20 mL = 20 units0.60 mL = 60 units1.20 mL = 120 units (two draws)1.80 mL = 180 units (two draws)
4 mg/mL (2.5 mL)0.25 mL = 25 units0.75 mL = 75 units1.5 mL = 150 units (two draws)2.25 mL = 225 units (three draws)

Units = mL × 100; mL = dose ÷ concentration. Doses are the once-weekly arms of the Phase 2 trial (Billings et al., The Lancet 2025); every cell has been re-checked against that arithmetic.

A worked example: a researcher modelling the 3→6→9 mg escalation arm at 10 mg/mL draws 30 units for each of the first four weekly doses, 60 units for the next four and 90 units from week nine onward, Lilly’s schedule for 52 Phase 2 participants. At 5 mg/mL the same arm needs 60 units, then two draws of 60, then two draws of 90, which is why the eloralintide reconstitution volume is decided before the first dose.

U-100 insulin syringe units for 1, 3, 6 and 9 mg eloralintide doses at 10, 5 and 4 mg/mL

Why the Concentration Choice Matters at 1 mg and at 9 mg

The two ends of the Phase 2 range pull an eloralintide reconstitution in opposite directions. At 10 mg/mL a 1 mg dose is only 10 units, so a one-unit misreading is a 10% error; at 4 mg/mL the same dose is 25 units and the same slip is a 4% error. At the other end, 9 mg at 10 mg/mL is one 90-unit draw, against 180 units over two syringes at 5 mg/mL and 225 over three at 4 mg/mL.

Multiple draws add punctures, handling time and the chance of a counting error, which is why a protocol built on the 6 and 9 mg arms almost always reconstitutes at 1.0 mL, and a protocol built on 1 mg often does not. The eloralintide dosage guide explains how each of those arms performed, and the calculator walkthrough shows how to confirm any cell in the table above.

How Many Vials a Protocol Consumes

Quantity planning belongs to eloralintide reconstitution because the 10 mg vial does not divide evenly into the larger doses: a 9 mg dose leaves 1 mg behind and a 6 mg dose leaves 4 mg. On the Phase 2 schedules, twelve weeks of 3→6→9 mg comes to 72 mg (7.2 vials, practically eight), twelve weeks of fixed 9 mg to 108 mg (11 vials if each leftover is drawn with the next vial, 12 if every dose comes from a fresh one), and the whole 48-week 3→6→9 mg schedule to 396 mg (about 40).

Remainders can be pooled only within the storage window discussed next, so in practice a high-dose protocol opens a fresh vial for every dose and treats the leftover milligram as the cost of a single-draw design. Low-dose work is the opposite case: ten 1 mg doses from one vial would span ten weeks, well beyond the 28-day convention, so a 1 mg weekly design uses four doses from a vial and discards the rest.

Storage Before and After Reconstitution

No eloralintide-specific stability study has been published, so storage follows the convention for lyophilized research peptides rather than a citation: the sealed vial is kept frozen or refrigerated and away from light, and after eloralintide reconstitution with bacteriostatic water it is held at 2–8 °C for no more than about 28 days. The reconstitution date on the label is what makes that window enforceable, and the peptide storage guide covers both states in more detail.

Two habits protect the solution between draws. The vial returns to the refrigerator immediately after each draw, and it is never frozen once reconstituted, since freeze-thaw cycles are avoided for peptide solutions by convention. Eloralintide reconstitution at 1.0 mL also keeps the number of punctures low, since a 6 or 9 mg protocol takes its dose in a single draw and a 3 mg protocol needs only three draws per vial.

Reconstitution Errors Seen in Practice and Their Corrections

ErrorConsequenceCorrection
Treating syringe units as milligramsAt 10 mg/mL, 30 units is 3 mg; at 5 mg/mL, 30 units is only 1.5 mgWrite the concentration and the mg-per-unit value on the vial label and convert every dose from it
Forcing the water directly onto the powderFoaming and slow or incomplete dissolutionWater down the inside of the glass, plunger pressed slowly
Shaking the vial to speed dissolutionAgitation of a peptide solutionSwirl or roll the vial and allow time
Using plain sterile water for a vial entered repeatedlyNo preservative for multi-dose useBacteriostatic water for any vial drawn from more than once
Reconstituting a vial straight from the freezerCondensation inside the cold vialEquilibrate to room temperature first
Leaving the vial unlabelledConcentration and date unknown; the 28-day window cannot be appliedDate, concentration, mg per unit and lot number on every vial
Trying to draw 9 mg at 5 mg/mL in one syringe180 units cannot fit a 100-unit syringeReconstitute at 1.0 mL for 6 and 9 mg work, or split into two draws of 90 units
Storing the reconstituted vial at room temperatureOutside the 2–8 °C conventionRefrigerate immediately after reconstitution and after each draw

Laboratory-handling conventions for lyophilized peptides; unit arithmetic as in the tables above.

The first row causes the most trouble because it is invisible: a syringe filled to 30 looks identical at every concentration. Labelling the vial with “1 unit = 0.1 mg” at the moment of reconstitution, before any dose is drawn, removes the ambiguity for every subsequent draw. The trials used subcutaneous administration, and our subcutaneous vs intramuscular injection article explains why that matters for the syringe used in an eloralintide reconstitution and draw.

Labelled reconstituted eloralintide vial with date, concentration and lot number beside bacteriostatic water and syringes

The 10 mg Vial, Its COA and the Supplies at PSPeptides

The eloralintide sold by PSPeptides comes as one 10 mg lyophilized vial, synthesized in a cGMP-compliant facility in Temecula, California. Independent accredited laboratories check each lot, HPLC purity at a 99%+ minimum and mass-spectrometry identity plus endotoxin, sterility, heavy-metal and fentanyl screens, as set out on the certifications page, and the lot’s certificate of analysis, published on the product page, is where the lot number for the reconstitution label comes from. Regulatory status is covered in the eloralintide research guide.

Bacteriostatic water, U-100 insulin syringes and the peptide injection pen are stocked alongside the vial so that an eloralintide reconstitution kit arrives in one order, and the free peptide calculator reproduces every unit figure above for any volume. Orders placed before 2 PM EST ship the same day, US shipping is free, and card, Afterpay and Klarna payments are accepted; current pricing and the lot COA are on the product page.

Buy eloralintide 10 mg · Buy bacteriostatic water

Frequently Asked Questions About Reconstituting Eloralintide

How much bacteriostatic water goes into a 10 mg eloralintide vial?

The standard choice is 1.0 mL, which gives 10 mg/mL and makes every Phase 2 dose a single draw: 10, 30, 60 and 90 units for 1, 3, 6 and 9 mg. Adding 2.0 mL gives 5 mg/mL and 2.5 mL gives 4 mg/mL, which at least doubles the units for each dose and pushes 6 and 9 mg beyond one syringe.

How many units is 1 mg of eloralintide?

It depends on the concentration: 10 units at 10 mg/mL (1.0 mL added), 20 units at 5 mg/mL (2.0 mL) and 25 units at 4 mg/mL (2.5 mL). A unit on a U-100 insulin syringe is 0.01 mL, so the units for any dose are the volume in millilitres multiplied by 100.

Can a 9 mg research dose be drawn in one syringe?

Only at 10 mg/mL, where 9 mg is 0.90 mL, or 90 units, and fits a 1 mL insulin syringe in a single draw. At 5 mg/mL the same dose is 1.80 mL (180 units) and needs two draws, and at 4 mg/mL it is 2.25 mL (225 units) and needs three.

How long is reconstituted eloralintide kept?

By the standard convention for lyophilized research peptides, a vial reconstituted with bacteriostatic water is refrigerated at 2–8 °C and used within about 28 days, while the unopened lyophilized vial is stored frozen or refrigerated away from light. No eloralintide-specific stability data have been published, so the convention rather than a study is the basis for that window.

References

  1. Eli Lilly, “What to know about eloralintide” (last updated September 2026). https://www.lilly.com/news/stories/what-to-know-about-eloralintide
  2. Billings LK, Hsia S, Bays H, et al. Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial. The Lancet. 2025;406(10520):2631–2643. https://doi.org/10.1016/S0140-6736(25)02155-5
  3. Briere DA, et al. Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept. Molecular Metabolism. 2025;102:102271. https://doi.org/10.1016/j.molmet.2025.102271

All PSPeptides products are sold exclusively for research and laboratory use.